Helping you make wiser investment decisions

Pharmaceuticals, health and wellness

Activist investor Elliott takes ‘significant’ stake in GlaxoSmithKline amid string of setbacks: report

GlaxoSmithKline has suffered a string of disappointments since the start of the year, prompting some Wall Street analysts to question the leadership of CEO Emma Walmsley. Now one hedge fund that’s known for its activist stance in biopharma and other industries is reportedly getting involved. Hedge fund Elliott Management, which has a history of agitating for […]

Safety concerns with J&J’s COVID-19 vaccine present a big opportunity for Pfizer, Moderna: analyst

Developing a single-shot COVID-19 vaccine with less stringent cold-storage requirements seemingly gave Johnson & Johnson a major advantage over mRNA coronavirus vaccine producers. As a result, its rollout was anxiously awaited. But with a pause of the J&J shot in the United States and Europe as officials investigate rare and severe blood clots, that edge is quickly diminishing. […]

Alexion’s pricey Ultomiris wins backing from England’s cost watchdogs thanks to confidential discount

Alexion has added a nice piece to Ultomiris’ growth potential ahead of its planned merger with AstraZeneca, scoring backing from England’s drug cost watchdog in a key indication. The C5 inhibitor now has full coverage on the National Health Service for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), thanks to a recommendation from the National […]

Novartis inks 3rd COVID-19 production pact, this time for Roche’s arthritis med Actemra

Novartis wasn’t kidding when it said it wanted to help with the global COVID-19 fight earlier this year. The company racked up back-to-back manufacturing pacts with Pfizer-BioNTech and CureVac, and, now, it’s taking the battle to the therapeutic front. Novartis has penned an initial deal with Roche to reserve active pharmaceutical ingredient (API) capacity for the company’s […]

Alnylam CEO Maraganore scored $7.8M in 2020 pay. Or was it $13.6M? Depends how you view the numbers

Alnylam has ambitious plans to join the ranks of the top five biotechs by market cap. And last year, CEO John Maraganore totted up compensation worthy of that ranking, more than the leaders of some Big Pharma companies. Or perhaps a few million less, depending how confident he might be in meeting his performance goals. […]

Eisai’s new awareness campaign asks women to look out for endometrial cancer—for each other

Sisterhood is at the core of Eisai’s awareness campaign for endometrial cancer. The digital and social effort “Spot Her” encourages women to not only look for the signs themselves—spotting and cramping, for instance—but also watch out for friends and talk more openly to break the stigma around endometrial cancer.   Despite being one of the most […]

Unsung COVID vaccine heroes—and biotech science giants—star on influencer’s TikTok

Ready to meet the science heroes behind the world’s first COVID vaccines? Ready to watch them dance on TikTok? Anna Blakney thinks you are. She’s an assistant professor and vaccine researcher at the University of British Columbia coaxing some of the mega-accomplished scientists behind the vaccines to join her in off-the-cuff choreography and conversation. So […]

CDC vaccine experts punt on Johnson & Johnson COVID-19 vaccine guidance, extending the pause

U.S. vaccine experts have identified three potential options for Johnson & Johnson’s COVID-19 vaccine in the U.S. going forward. But while they wait for more data, the shot’s nationwide pause will continue. Moving forward, the United States could continue the vaccine’s use with a safety warning, or it could put age and gender restrictions on the product. Officials could also discontinue use of […]

Biden expands his list of potential nominees to lead FDA as pressure mounts to make a pick: WSJ

Despite facing mounting pressure to pick a permanent FDA commissioner amid the ongoing COVID-19 pandemic, it appears President Joe Biden’s pool of potential candidates is only growing larger.  The Biden administration has expanded its shortlist of candidates to lead the FDA, which now includes several women of color, The Wall Street Journal reported Wednesday, citing a person […]

A year after buyout, Lilly to shutter Dermira’s Menlo Park facility and shed 163 jobs

Eli Lilly took a sizable leap into the dermatology market last year with its $1.1 billion acquisition of Dermira, picking up Qbrexza, the medicated cloth for excessive sweating, and a potential rival to Regeneron and Sanofi’s atopic dermatitis blockbuster Dupixent. Now, about a year later, Lilly is selling Qbrexza and plans to shutter Dermira’s Menlo Park facility, […]

On a roll, Gilead snags 2nd Trodelvy nod—in bladder cancer—but Seagen and Astellas have set the bar high

On the heels of turning a conditional FDA nod for Trodelvy in triple-negative breast cancer into a full one, Gilead Sciences has snatched a second green light for the antibody-drug conjugate, this time in bladder cancer. But thanks to competitive data from a rival, pharma watchers have low sales expectations for the new indication. The FDA […]

Abzena blueprints $200M biologics plant in North Carolina, where it plans to hire 325

Partner research organization Abzena last year tweaked its San Diego site to dive into commercial biologics production. Now, it’s following that initial foray with a big biomanufacturing splash at a new U.S. site. Abzena will invest more than $200 million into a new biologics manufacturing facility in Sanford, North Carolina, as the company faces increased demand from customers looking to take […]